^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ALG.APV-527

    i
    Other names: ALG.APV-527, ADC-1016, ATOR-1016, ALG.APV 527, ADC 1016, ATOR 1016
    Company:
    Alligator Biosci, Aptevo Therap
    Drug class:
    CD137 agonist, 5T4 inhibitor
    Related drugs:
    over1year
    ALG.APV-527 First-in-human Study (clinicaltrials.gov)
    P1/2, N=56, Recruiting, Aptevo Therapeutics
    New P1/2 trial • Metastases
    |
    ALG.APV-527